Skip to main content

Table 1 Demographic and clinical characteristics of validation study sample

From: Positive predictive value of automated database records for diabetic ketoacidosis (DKA) in children and youth exposed to antipsychotic drugs or control medications: a tennessee medicaid study

Characteristica

All cases

Adjudicated

N

30

27

Age, years, median (IQR)

11 (7-14)

11 (8-15)

Gender, no. (%) female

14 (46.7)

13 (48.1)

Race, no. (%)

  

   Caucasian

21 (70.0)

19 (70.4)

   African-American

6 (20.0)

6 (22.2)

   Other

3 (10.0)

2 (7.4)

Urban dwelling, no. (%)

19 (63.3)

17 (63.0)

General medical diagnoses, no. (%)

  

   Any

15 (50.0)

14 (51.9)

   Cardiovascular

1 (3.3)

1 (3.7)

   Endocrine (non-diabetic, non-DKA)

0

0

   Injury

5 (16.7)

5 (18.5)

   Rheumatologic

2 (6.7)

1 (3.7)

   Pregnancy

1 (3.3)

1 (3.7)

Psychiatric diagnoses, no. (%)

  

   Mood disorder

9 (30.0)

8 (29.6)

   Anxiety disorder

3 (10.0)

3 (11.1)

   Attention deficit-hyperactivity disorder

16 (53.3)

15 (55.6)

   Externalizing/impulse control disorders

6 (20.0)

5 (18.5)

   Acute stress/adjustment disorders

5 (16.7)

3 (11.1)

Outpatient visits, median no. (IQR)b

3 (1-10)

3 (1-10)

Medications, psychotropic, no. (%)

  

   Antipsychotic drug

6 (20.0)

6 (22.2)

   Antidepressant, SSRI or SNRI

9 (30.0)

9 (33.3)

   Antidepressant, tricyclic

3 (10.0)

3 (11.1)

   Antidepressant, other

1 (3.3)

1 (3.7)

   ADHD (stimulants, atomoxetine)

22 (73.3)

19 (70.4)

   Benzodiazepine

4 (13.3)

4 (14.8)

   Mood stabilizer (VPA, CBMZ, LAM)

2 (6.7)

2 (7.4)

  1. a Corresponds with the value at the beginning of follow-up (t0) in the study cohort, unless otherwise specified.
  2. b Corresponds with the value during the year prior to the beginning of follow-up in the study cohort (e.g., the time interval [t0-365 days, t0]).
  3. Key: ADHD = attention deficit-hyperactivity disorder, CBMZ = carbamazepine, LAM = lamotrigine, SNRI = serotonin-norepinephrine re-uptake inhibitor (venlafaxine, duloxetine), SSRI = selective serotonin re-uptake inhibitor (fluoxetine, paroxetine, sertraline, citalopram, fluvoxamine, escitalopram), VPA = valproic acid.